WATERTOWN, Mass. – C4 Therapeutics (C4T) today announced the appointment of Ryan B. Corcoran, M.D., Ph.D., to the Company’s Scientific Advisory Board
WATERTOWN, Mass. – March 13, 2019 – C4 Therapeutics (C4T) today announced the appointment of Adam Crystal M.D., Ph.D. as
WATERTOWN, Mass. – C4 Therapeutics (C4T) today announced the transformation of its ongoing research and development partnership with Roche focusing
C4T’s targeted protein degradation platform provides a novel approach to neuroscience drug discovery and development, complementing Biogen’s broader research and
